BRIEF-Standard Biotools Announces Sale Of Mass Cytometry Business And Illumina’S Buyout Of Contingent Payments To Advance Merger With Treeline Biosciences

Reuters2026/07/28 12:13

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

July 28 (Reuters) - Standard BioTools Inc LAB.O:

STANDARD BIOTOOLS ANNOUNCES SALE OF MASS CYTOMETRY BUSINESS AND ILLUMINA’S BUYOUT OF CONTINGENT PAYMENTS TO ADVANCE MERGER WITH TREELINE BIOSCIENCES
STANDARD BIOTOOLS - TO SELL MASS CYTOMETRY BUSINESS TO MULTIPLEX BIO
STANDARD BIOTOOLS - MASS CYTOMETRY BUSINESS SALE VALUED AT UP TO $10 MILLION

Source text: ID:nGNX8sbBPh

Further company coverage: LAB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRIEF-Standard Biotools Announces Sale Of Mass Cytometry Business And Illumina’S Buyout Of Contingent Payments To Advance Merger With Treeline Biosciences

You may also like

Crypto prices